The Australian government has asked the nation’s medical regulator to further investigate links between AstraZeneca’s coronavirus vaccine and blood-clotting issues.
Chief Medical Officer Paul Kelly said on Thursday that the Australian Technical Advisory Group on Immunisation (ATAGI) and Therapeutic Goods Administration (TGA) would meet to urgently consider the European Medicines Agency’s finding of a possible link between the vaccines and blood clots.
In spite of concerns, Prime Minister, Scott Morrison, said the benefits of the vaccine outweighed the risk.
“We need to consider the positive benefits of them. But what we’re looking at here is an incidence of these clotting behaviour of some one-to-five for every million.
“And so what ATAGI will be doing is they’ll be looking at that evidence and they, of course, will be weighing that against the very positive benefits of the vaccine programme and then they’ll be providing further advice,” he told reporters in Canberra.